XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Total revenues, net $ 65,697,756 $ 44,144,264
Cost of revenues    
Total cost of revenues 8,643,716 4,600,177
Gross profit 57,054,040 39,544,087
Expenses    
Selling and marketing expenses 29,194,061 24,173,880
General and administrative expenses 17,055,669 15,305,732
Customer service expenses 3,071,494 1,848,041
Development costs 2,675,134 2,087,232
Other operating expenses 2,514,758 2,300,447
Total expenses 54,511,116 45,715,332
Operating income (loss) 2,542,924 (6,171,245)
Interest expense, net (626,275) (477,678)
Net income (loss) 1,916,649 (6,648,923)
Net income attributable to non-controlling interest 531,845 119,432
Net income (loss) attributable to LifeMD, Inc. 1,384,804 (6,768,355)
Preferred stock dividends (776,563) (776,563)
Net income (loss) attributable to LifeMD, Inc. common stockholders $ 608,241 $ (7,544,918)
Basic earnings (loss) per share attributable to LifeMD, Inc. common stockholders $ 0.01 $ (0.19)
Diluted earnings (loss) per share attributable to LifeMD, Inc. common stockholders $ 0.01 $ (0.19)
Weighted average number of common shares outstanding:    
Basic 43,135,778 39,242,237
Diluted 45,580,311 39,242,237
Telehealth Revenue [Member]    
Revenues    
Total revenues, net $ 52,456,481 $ 30,841,402
Cost of revenues    
Total cost of revenues 8,136,462 4,194,595
WorkSimpli Revenue [Member]    
Revenues    
Total revenues, net 13,241,275 13,302,862
Cost of revenues    
Total cost of revenues $ 507,254 $ 405,582